Snapshot from Sep 18, 2026 at 07:00 UTC. For live data and tracking: View Live
Business Investor Relations

Nurix Therapeutics Investor Conference Participation

Analysis based on 6 articles · First reported Sep 01, 2026 · Last updated Sep 01, 2026

Sentiment
0
Attention
0
Articles
6
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard

The announcement is a routine investor relations activity with minimal direct market impact. It may provide a platform for Nurix to communicate pipeline updates and potentially influence investor sentiment in the short term.

Biotechnology Pharmaceuticals

Nurix Therapeutics, Inc. announced that its management will participate in fireside chats at four upcoming investor conferences in September 2026: the Wells Fargo Healthcare Conference on September 8, the H.C. Wainwright Healthcare Conference on September 14, the Baird Healthcare Conference on September 15, and the Morgan Stanley Healthcare Conference on September 16. The fireside chats will be webcast live and archived on the company's website for 30 days. Nurix is a clinical-stage biopharmaceutical company focused on targeted protein degradation medicines for cancer and autoimmune diseases. Its pipeline includes collaborations with Roche, Gilead Sciences, Sanofi, and Pfizer.

stock
Nurix is the subject of the announcement, participating in investor conferences to present its pipeline and collaborations. The event is a routine investor relations activity with no material change to its business.
Importance 100.0 Sentiment 0.0
stock
Pfizer is a collaboration partner of Nurix, with agreements for multiple drug candidates. The conference participation may highlight this collaboration, but no material impact on Pfizer is expected.
Importance 20.0 Sentiment 0.0
stock
Gilead is a collaboration partner of Nurix, working on IRAK-4 degraders. The conference participation may highlight this collaboration, but no material impact on Gilead is expected.
Importance 20.0 Sentiment 0.0
stock
Sanofi is a collaboration partner of Nurix, working on STAT6 degraders. The conference participation may highlight this collaboration, but no material impact on Sanofi is expected.
Importance 20.0 Sentiment 0.0
stock
Roche is a collaboration partner of Nurix, co-developing bexobrutideg. The conference participation may highlight this collaboration, but no material impact on Roche is expected.
Importance 20.0 Sentiment 0.0
stock
Morgan Stanley is hosting one of the investor conferences where Nurix will present. This is a routine event hosting activity with no material impact on Morgan Stanley.
Importance 10.0 Sentiment 0.0
stock
Wells Fargo is hosting one of the investor conferences where Nurix will present. This is a routine event hosting activity with no material impact on Wells Fargo.
Importance 10.0 Sentiment 0.0
priv
H.C. Wainwright is hosting one of the investor conferences where Nurix will present. This is a routine event hosting activity with no material impact on H.C. Wainwright.
Importance 10.0 Sentiment 0.0
priv
Baird is hosting one of the investor conferences where Nurix will present. This is a routine event hosting activity with no material impact on Baird.
Importance 10.0 Sentiment 0.0
Pfizer related ↔ Sanofi
Sanofi related ↔ Roche
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.